We next used KP9-3, a C57B/L6-derived murine lung adenocarcinoma cell line driven by oncogenic Kras and Tp53 loss, to test the radiosensitization strategy in a syngeneic model (51). This evidence concerns the gene TP53 and lung adenocarcinoma.